If a House appropriations subcommittee has its say, theUS Food and Drug Administration’s device center would receive $420m in congressional budget authority in fiscal year 2020 – a raise of 8.5% over the current year’s spending level of $387m. The bill was approved on May 23 by an agriculture and FDA subpanel of the House Committee on Appropriations.
The addition of $219.5m in device user fees slated for 2020, plus the proposed $33m raise, means that device center personnel at FDA would have approximately $606.5m total to review...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?